Relmada Therapeutics' Series B Round

Relmada Therapeutics raised a round of funding on May 22, 2014.

Relmada Therapeutics is a clinical stage, private biopharmaceutical company with a diversified portfolio of four products and a deep early stage pipeline for the treatment of pain. Relmada's strategy …

Articles about Relmada Therapeutics' Series B Round: